TWISTNB Activators
TWISTNB Activators encompass a collection of chemical compounds that influence various signaling pathways and cellular processes, leading to the enhancement of TWISTNB activity. Forskolin, through the elevation of cAMP levels, activates protein kinase A, which could phosphorylate transcriptional regulators that interact with TWISTNB, thereby enhancing its function in cellular differentiation and development. Retinoic Acid, by engaging with its receptors, can modulate gene expression to favor TWISTNB's activity, particularly in developmental processes. Furthermore, the inhibition of various kinases by Epigallocatechin gallate (EGCG) potentially reduces the suppressive phosphorylation on proteins that would otherwise hinder TWISTNB's role, thus promoting its functional activity. PMA's activation of protein kinase C could lead to phosphorylation events that enhance TWISTNB's involvement in cellular processes, while Sphingosine-1-phosphate (S1P) triggers downstream signaling that could bolster TWISTNB's function in migration and angiogenesis.
Complementing these, Thapsigargin and A23187 (Calcimycin) heighten intracellular calcium levels, which activates calcium-dependent signaling that may augment TWISTNB activity, a crucial component in various cellular signaling mechanisms. The inhibition of specific kinases by LY294002, SB203580, and U0126 might shift cellular signaling in favor of pathways that activate TWISTNB, without the need for direct activation or increased expression of the protein. Staurosporine, although a broad-spectrum inhibitor, could indirectly potentiate TWISTNB's activity by alleviating the suppression by specific kinases on TWISTNB-associated pathways. Lastly, 5-Azacytidine, by inhibiting DNA methyltransferases, could lead to the upregulation of genes that support or are involvedin the various cellular functions attributed to TWISTNB. Each of these chemical activators operate through distinct molecular interactions and signaling cascades, ultimately converging on the enhancement of TWISTNB's role within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn activates PKA. PKA phosphorylates target proteins that could enhance the activity of TWISTNB by influencing transcription factors and co-factors associated with TWISTNB. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid binds to retinoic acid receptors which regulate gene expression. This binding can lead to the upregulation of genes that synergize with TWISTNB function in cell differentiation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG inhibits several kinases, potentially reducing the phosphorylation of inhibitory proteins that would otherwise suppress TWISTNB function, thus enhancing its activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate and activate proteins within signaling pathways that promote functions associated with TWISTNB. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors, leading to activation of downstream signaling cascades that could enhance TWISTNB activity by promoting cellular processes such as migration and angiogenesis. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin increases intracellular calcium levels, which activates calcium-dependent kinases and phosphatases potentially enhancing the activity of TWISTNB in calcium-dependent signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can shift signaling dynamics, potentially enhancing pathways that upregulate or activate TWISTNB. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may enhance TWISTNB activity by altering the balance of MAPK signaling pathways, potentially favoring those that activate TWISTNB. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which could lead to the enhancement of TWISTNB activity by shifting the signaling equilibrium towards pathways that involve TWISTNB. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, potentially activating TWISTNB by promoting calcium-dependent signaling processes. | ||||||